UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)
0.7268 +0.0281 (+4.02%) 14:50 ET [NASDAQ]
0.7273 x 200 0.7278 x 119
Realtime by (Cboe BZX)
0.7273 x 200 0.7278 x 119
Realtime 0.6941 -0.0046 (-) 09:23 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.6762
Day High
0.7379
Open 0.6948
Previous Close 0.6987 0.6987
Volume 4,553,641 4,553,641
Avg Vol 11,730,311 11,730,311
Stochastic %K 38.92% 38.92%
Weighted Alpha -46.77 -46.77
5-Day Change +0.0977 (+15.70%) +0.0977 (+15.70%)
52-Week Range 0.3040 - 3.1790 0.3040 - 3.1790
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 157,005
  • Shares Outstanding, K 224,710
  • Annual Sales, $ 57,800 K
  • Annual Income, $ -97,940 K
  • EBIT $ -104 M
  • EBITDA $ -95 M
  • 60-Month Beta 1.57
  • Price/Sales 2.44
  • Price/Cash Flow N/A
  • Price/Book 5.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.51
  • Most Recent Earnings $-0.11 on 03/17/25
  • Next Earnings Date 05/08/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 251.75% ( -31.66%)
  • Historical Volatility 132.89%
  • IV Percentile 88%
  • IV Rank 41.12%
  • IV High 517.32% on 05/23/24
  • IV Low 66.32% on 05/08/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 393
  • Volume Avg (30-Day) 3,456
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 100,826
  • Open Int (30-Day) 104,576

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.11
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.15
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +59.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5250 +37.14%
on 04/07/25
Period Open: 0.9886
1.0500 -31.43%
on 03/12/25
-0.2686 (-27.17%)
since 03/10/25
3-Month
0.5250 +37.14%
on 04/07/25
Period Open: 1.1650
1.4000 -48.57%
on 02/06/25
-0.4450 (-38.20%)
since 01/10/25
52-Week
0.3040 +136.84%
on 07/05/24
Period Open: 0.5240
3.1790 -77.35%
on 11/08/24
+0.1960 (+37.40%)
since 04/10/24

Most Recent Stories

More News
Stocks Set to Extend Tariff-Driven Selloff as China Retaliates, U.S. Jobs Report and Powell Speech in Focus

June S&P 500 E-Mini futures (ESM25) are down -2.33%, and June Nasdaq 100 E-Mini futures (NQM25) are down -2.71% this morning, pointing to a continued selloff on Wall Street following U.S. President Donald...

GOOGL : 154.26 (-2.80%)
META : 551.10 (-5.92%)
NVDA : 108.45 (-5.14%)
AAPL : 191.33 (-3.78%)
GXI.D.DX : 54.050 (+1.03%)
MU : 70.32 (-9.70%)
LW : 54.35 (-1.65%)
GS : 490.54 (-5.09%)
MSFT : 379.96 (-2.70%)
SGMO : 0.7268 (+4.02%)
ESM25 : 5,331.25 (-2.91%)
TSLA : 254.76 (-6.41%)
Eli Lilly Stock Drops As Trump Tariff Chaos Hits Markets, But Retail Finds Comfort In Big Pharma’s Exemption

On Stocktwits, message volume about Lilly jumped by 23% over the past 24 hours, with retail sentiment turning more ‘bullish.’

SGMO : 0.7268 (+4.02%)
XLV : 135.91 (-2.05%)
LLY : 726.70 (-3.58%)
Sangamo Therapeutics Retail Traders Keep The Faith Even As Stock Slides After-Hours On Q4 Miss

Several optimistic users expressed confidence in the company securing a third potential agreement with a major pharma for its adeno-associated virus (AAV) capsid, STAC-BBB.

SGMO : 0.7268 (+4.02%)
VTI : 258.79 (-3.61%)
XBI : 72.30 (-3.45%)
SCHA : 21.41 (-4.03%)
Sangamo: Q4 Earnings Snapshot

Sangamo: Q4 Earnings Snapshot

SGMO : 0.7268 (+4.02%)
Stocks Climb Before the Open on Tech Boost, U.S. Economic Data in Focus

March S&P 500 E-Mini futures (ESH25) are up +0.56%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.73% this morning as trading resumed after the New Year’s Day holiday, with investors awaiting...

NVDA : 108.45 (-5.14%)
META : 551.10 (-5.92%)
GOOGL : 154.26 (-2.80%)
AAPL : 191.33 (-3.78%)
MU : 70.32 (-9.70%)
ESH25 : 5,617.80s (-0.79%)
SGMO : 0.7268 (+4.02%)
MSFT : 379.96 (-2.70%)
TSLA : 254.76 (-6.41%)
VWS.C.DX : 85.600 (+2.80%)
X : 42.25 (-6.40%)
AMD : 88.53 (-8.58%)
Stock Index Futures Gain at the End of a Bumper Year

March S&P 500 E-Mini futures (ESH25) are up +0.26%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.30% this morning, pointing to a positive start on Wall Street in the final trading session of 2024....

MSTR : 276.44 (-6.88%)
META : 551.10 (-5.92%)
MU : 70.32 (-9.70%)
AAL : 9.79 (-11.96%)
ESH25 : 5,617.80s (-0.79%)
SGMO : 0.7268 (+4.02%)
TSLA : 254.76 (-6.41%)
WIZZ.LN : 1,400.000 (-2.44%)
DAVE : 85.17 (-2.44%)
CMPO : 10.42 (-0.86%)
NQH25 : 19,450.81s (-1.16%)
RL : 194.62 (-6.60%)
Sangamo Therapeutics Stock Slips On Termination of Pfizer Collaboration: Retail’s Cautious

Sangamo intends to explore all options to advance the program,

SGMO : 0.7268 (+4.02%)
PRFZ : 34.62 (-3.73%)
VTI : 258.79 (-3.61%)
PFE : 21.70 (-3.51%)
Nasdaq Futures Gain With Focus on Nvidia Earnings

December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.14% this morning as investors shifted their focus to a highly anticipated earnings report from AI darling Nvidia.

TGT : 92.22 (-5.60%)
NVDA : 108.45 (-5.14%)
TJX : 127.89 (+1.46%)
SNOW : 145.39 (-3.81%)
SMCI : 34.03 (-7.30%)
NQZ24 : 20,947.98s (-0.78%)
SGMO : 0.7268 (+4.02%)
POWL : 175.74 (-4.06%)
SGE.LN : 1,142.000 (+3.68%)
KEYS : 133.77 (-6.13%)
CHWY : 32.89 (-1.20%)
INCY : 55.82 (-5.16%)
Sangamo: Q3 Earnings Snapshot

Sangamo: Q3 Earnings Snapshot

SGMO : 0.7268 (+4.02%)
3 Penny Stocks With 66% to 245% Upside Potential

Investing in these penny stocks could unlock extraordinary gains, with expected returns of up to 245%. Here are three analyst-recommended stocks from in-demand industries, all with significant upside potential....

AAPL : 191.33 (-3.78%)
AMZN : 182.49 (-4.51%)
LUNR : 7.97 (-4.89%)
SGMO : 0.7268 (+4.02%)
SVM : 3.61 (+0.56%)
$SPX : 5,280.64 (-3.23%)
PFE : 21.70 (-3.51%)
SIU24 : 32.025s (+1.03%)
GCZ24 : 2,617.2s (-0.82%)

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.8671
2nd Resistance Point 0.7916
1st Resistance Point 0.7451
Last Price 0.7268
1st Support Level 0.6231
2nd Support Level 0.5476
3rd Support Level 0.5011

See More

52-Week High 3.1790
Fibonacci 61.8% 2.0807
Fibonacci 50% 1.7415
Fibonacci 38.2% 1.4022
Last Price 0.7268
52-Week Low 0.3040

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar